Cited by 525CRISPR and Genetic EngineeringRNA regulation and diseaseCAR-T cell therapy research

Directed evolution of CRISPR-Cas9 to increase its specificity

Open access
Lee, Jungjoon K., Jeong, Euihwan, Lee, Joonsun, Jung, Minhee, Shin, Eunji, Kim, Young-hoon, Lee, Kangin, Jung, Inyoung +3 more·2018·Nature Communications

Published version of a preprint

Abstract

The use of CRISPR-Cas9 as a therapeutic reagent is hampered by its off-target effects. Although rationally designed S. pyogenes Cas9 (SpCas9) variants that display higher specificities than the wild-type SpCas9 protein are available, these attenuated Cas9 variants are often poorly efficient in human cells. Here, we develop a directed evolution approach in E. coli to obtain Sniper-Cas9, which shows high specificities without killing on-target activities in human cells. Unlike other engineered Cas9 variants, Sniper-Cas9 shows WT-level on-target activities with extended or truncated sgRNAs with further reduced off-target activities and works well in a preassembled ribonucleoprotein (RNP) format to allow DNA-free genome editing.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-018-05477-x

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In several previous reports, LZ3 Cas9, Sniper Cas9, and HiFi Cas9 had comparable editing activity to SpCas9-WT in human cells or other animal embryos.

    “It worth mentioning that in several previous reports, LZ3 Cas9, Sniper Cas9, and HiFi Cas9 had comparable editing activity to the SpCas9-WT in human cells or other animal embryos.”

    From Machine learning-based prediction models to guide the selection of Cas9 variants for efficient gene editing (2024) · cites this paper as [21]

    The Results section (“Clone selection and characterization”; page unavailable) reports that Sniper-Cas9 had on-target activity comparable to WT-Cas9 in human HEK293T cells. Our copy does not establish the corresponding claim for LZ3 Cas9 or HiFi Cas9, or for animal embryos. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lee, J. K., Jeong, E., Lee, J., Jung, M., Shin, E., Kim, Y.-H., Lee, K., Jung, I., Kim, D., Kim, S., & Kim, J.-S.
Affiliations
  • ToolGen (South Korea) (KR)
  • Seoul National University (KR)
Corresponding author
  • Lee, Jungjoon K.
  • Lee, Joonsun
Venue
Nature Communications
Published
2018-08-06
Volume
9
Issue
1
Pages
3048-3048
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2781931843
Cited by
525
References
40
Citations by year
2026: 30 · 2025: 61 · 2024: 69 · 2023: 61 · 2022: 99 · 2021: 76 · 2020: 69 · 2019: 53 · 2018: 5
FWCI
18.05
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Seoul National University Open Repository (Seoul National University) (submittedVersion)
Funders
  • National Research Foundation (2018M3A9H3020844, 2017M3A9B4061404)
  • National Research Foundation of Korea (2017M3A9B4061404, 2017M3A9B4061406, 2018M3A9H3020844)
  • Institute for Basic Science (IBSR021-D1, R021-D1)
  • Ministry of Science and ICT, South Korea (2018M3A9H3020844)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
Keywords
CRISPR/Cas9, directed evolution, off-target effects, DNA-free genome editing, single guide RNA, on-target activity, human cells
MeSH terms
Gene Editing, RNA, Guide, CRISPR-Cas Systems, DNA, Escherichia coli, Humans, Plasmids, Recombinant Proteins, Ribonucleoproteins, Substrate Specificity, RNA, Guide, Kinetoplastida, Directed Molecular Evolution, HEK293 Cells, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review